TGFB1 and ovarian carcinoma: However, a notably high percentage of stage IV patients clustered into PG3 while all stage IC and two stage IIC patients clustered into PG4, despite a similar number of stage IIIC patients in each (Table S8), perhaps indicating that TGFβ/SMAD4 regulated genes could be potentially used to classify a subtype of ovarian cancer patients.